Yüklüyor......
Multiple Myeloma: 2018 update on Diagnosis, Risk-stratification and Management
DISEASE OVERVIEW: Multiple myeloma accounts for approximately 10% of hematologic malignancies. DIAGNOSIS: The diagnosis requires ≥10% clonal bone marrow plasma cells or a biopsy proven plasmacytoma plus evidence of one or more multiple myeloma defining events (MDE): CRAB (hypercalcemia, renal failur...
Kaydedildi:
| Yayımlandı: | Am J Hematol |
|---|---|
| Yazar: | |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6223128/ https://ncbi.nlm.nih.gov/pubmed/30400719 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.25117 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|